TI
AXSM icon

Tidal Investments’s Axsome Therapeutics AXSM Stock Holding History

Tidal Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,685
Closed -$623K – 2617
2026
Q1 		$623K Sell
3,685
-834
-18% -$144K ﹤0.01% 1726
2025
Q4 		$825K Buy
4,519
+498
+12% +$69.5K ﹤0.01% 1378
2025
Q3 		$488K Sell
4,021
-204
-5% -$23K ﹤0.01% 1584
2025
Q2 		$441K Buy
+4,225
New +$447K ﹤0.01% 1485

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Tidal Investments's AXSM Position: Q2 2026 in Review

Tidal Investments sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 3,685 shares — an estimated $623K sold.

Tidal Investments first reported a position in AXSM in Q2 2025 and held it in 4 quarters. The position peaked at $825K in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Tidal Investments reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Tidal Investments sold 3,685 Axsome Therapeutics shares in Q2 2026, an estimated $623K.
  • Tidal Investments first reported a position in Axsome Therapeutics in Q2 2025 and held it in 4 quarters.
  • Tidal Investments's Axsome Therapeutics position peaked at $825K in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.